COMPANY PROFILE / #3153
AiM Medical Robotics
Worcester, MAVenture Capital-Backed
OVERVIEW
Developer of a compatible surgical robot designed to increase outcomes for patients undergoing neurosurgery for functional brain disorders. The company's surgical robotic platform combines surgical planning and procedure with MR functional robotics, providing precise trajectory guidance for neurosurgical procedures, enabling healthcare providers to improve patient outcomes.
已融资11.50
最新估值34.00
员工数22
成立年份2018
公司概况
- Companies
- AiM Medical Robotics
- Description
- Developer of a compatible surgical robot designed to increase outcomes for patients undergoing neurosurgery for functional brain disorders. The company's surgical robotic platform combines surgical planning and procedure with MR functional robotics, providing precise trajectory guidance for neurosurgical procedures, enabling healthcare providers to improve patient outcomes.
- Website
- www.aimmedicalrobotics.com
- HQ Location
- Worcester, MA
- Year Founded
- 2018
- Keywords
- autonomous machine, image-guided system, intelligent robotics, medical robotics, neurosurgery care, robotic platform, surgical planning, surgical robotics
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 11.50
- First Financing Date
- 15-Mar-2022
- First Financing Size
- 3.40
- First Financing Valuation
- —
- Last Financing Date
- 04-Jun-2025
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 8.10
- Last Financing Valuation
- 34.00
- Last Financing Status
- Completed
- Last Known Valuation
- 34.00
- Last Known Valuation Date
- 04-Jun-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 57.76
- Valuation Estimate Growth Rate
- 69.87%
- Active Investors
- 1540 Ventures, Angel Star Ventures, Cancer Research Horizons, Harvard Business School Alumni Angels of Chicago, IQ Capital Partners, Keiretsu Forum, MassRobotics, New York Angels, SWAN Impact Network, Symbiotic Ventures, The Lambda Funds, The Sontag Foundation, TripleRing, Worcester Polytechnic Institute Endowment
- # Active Investors
- 14
- Acquirers
- —
团队与联系人
- Employees
- 22
- Employee Growth %
- 37.50% E
- Employee History
- 2026: 22, 2025: 16 E, 2024: 9, 2023: 9, 2022: 8, 2021: 5
- Primary Contact
- Craig Pierson
- Primary Contact Title
- Co-Founder
- Primary Contact Email
- cpierson@kaida-biopharma.com
- Primary Contact Phone
- +1 (917) 683-3092
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.61%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 95
- Size Multiple
- 3.24x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 76
- Majestic Referring Domains
- 97
- SimilarWeb Unique Visitors
- 181
- SimilarWeb Unique Visitors Change
- 38
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 5%
- Success Probability Over Time – 3 Year
- 17%
- Success Probability Over Time – 5 Year
- 32%
记录来源：public.companies · 原始序号 #3153 · 所有字段均按数据库原值展示。